Avanos Medical, Inc.

NYSE:AVNS

Medical - Devices

Healthcare
$24.99 +0.22%

+$0.06 today

Market cap
$1.17B
Beta
1.57
P/E (TTM)
-16.7
EPS (TTM)
-$1.50
52W Low $9.30High $25.49

Volume 0.43M

Average 1.49M

AVNS Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Avanos Medical, Inc.NYSE: AVNS

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) dips below year-ago levels

Q1 FY2026 weighted avg shares (diluted) of 46.4M shares fell 0.9% year over year, behind the +0.2% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at -0.6% a year.

Context

  • Weighted avg shares (diluted) increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -0.9% toward the trailing-twelve-month pace of +0.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
46.4M+0.0% QoQ
Last fiscal yearDec 2025
46.4M+0.9% YoY
LTMMar 2026
46.5M+0.2% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-0.9%——
1 year+0.9%——
3-year CAGR-0.6%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
46.4M USD
Year-over-year change
+0.9%
4-year CAGR
-1.2%

Weighted Avg Shares (Diluted) vs competitors

How AVNS compares with its peers on the latest reported figures

  • AVNS's LTM Mar 2026 weighted avg shares (diluted) of 46.5M shares is the 8th highest of the 11 companies compared; the peer median is 69.24M shares.
  • Its year-over-year change of +0.2% is the 9th highest of 11, against a peer median of +4.8%.
  • Over three fiscal years its annual growth of -0.6% compares with a peer median of +7.8%.
AVNS Competitors Peer median
Weighted Avg Shares (Diluted) for AVNS and competitors
Company Period LTM YoY 3-year CAGR
LABStandard BioTools Inc.LTM Mar 2026384.09M +2.7%+69.5%
PACBPacific Biosciences of California, Inc.LTM Mar 2026302.18M +5.2%+10.1%
CYHCommunity Health Systems, Inc.LTM Mar 2026135M +2.0%+1.3%
CTKBCytek Biosciences, Inc.LTM Mar 2026127.84M -2.0%-2.7%
BCYCBicycle Therapeutics plcLTM Mar 202669.4M +7.1%+32.7%
BVSBioventus Inc.LTM Mar 202669.07M +6.0%+3.9%
FDMT4D Molecular Therapeutics, Inc.LTM Mar 202659.51M +7.9%+21.4%
AVNSAvanos Medical, Inc.LTM Mar 202646.5M +0.2%-0.6%
VREXVarex Imaging CorporationLTM Apr 202641.88M -3.9%-0.2%
CBLLCeriBell, Inc.LTM Mar 202637M +38.8%+16.1%
CLPTClearPoint Neuro, Inc.LTM Mar 202628.64M +4.3%+5.4%
Peer median (excluding AVNS) 69.24M+4.8%+7.8%

Competitors are the stored peer set for AVNS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue744.6M684.1M673.3M687.8M701.2M
Cost of Revenue364.7M289.9M293.6M306.5M352.2M
Gross Profit379.9M394.2M379.7M381.3M349M
Gross Margin51.0%57.6%56.4%55.4%49.8%
Research & Development32.3M30.6M27.2M26.2M23.1M
Selling, General & Admin260.8M323.1M287.5M315.1M218.3M
Operating Expenses293.1M352.3M314.7M341.3M410.6M
Depreciation & Amortization38.3M41.1M43.5M45.5M29M
EBITDA48.9M77.8M50.6M(345.6M)(33.2M)
EBITDA Margin6.6%11.4%7.5%-50.2%-4.7%
Operating Income86.8M41.9M65M40M(61.6M)
Operating Margin11.7%6.1%9.7%5.8%-8.8%
Interest Income200K1.2M2.9M5.1M3.2M
Interest Expense3.3M10M15M12.2M4M
Other Income / Expenses(79.5M)(15.2M)(72.9M)(443.3M)(4.6M)
Income Before Tax7.3M26.7M(7.9M)(403.3M)(66.2M)
Pre-Tax Margin1.0%3.9%-1.2%-58.6%-9.4%
Income Tax Expense1M5.2M2M(17M)1.7M
Net Income6.3M50.5M(61.8M)(392.1M)(67.9M)
Net Margin0.8%7.4%-9.2%-57.0%-9.7%
EPS (Basic)0.131.08(1.33)(8.53)(1.46)
EPS (Diluted)0.131.07(1.33)(8.53)(1.46)
Weighted Avg Shares48.1M46.9M46.6M46M46.4M
Weighted Avg Shares (Diluted)48.6M47.3M46.6M46M46.4M

Avanos Medical, Inc.

NYSE:AVNS

Intrinsic Alpha fair value

Locked

Current Price

$24.99

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.